国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

AstraZeneca China signs major deal with UK company Medcity

By Liu Zhihua | chinadaily.com.cn | Updated: 2022-12-15 21:14
Share
Share - WeChat
Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. [Photo/Agencies]

AstraZeneca China signed a major collaboration agreement with the UK life and health sciences incubation platform MedCity on Thursday during the 2022 Beijing Intelligent Health Technology and Innovation Forum which was held online, a move to promote innovation exchange between Chinese and global healthcare industries.

Through this partnership, AstraZeneca's innovation hub iCampus will work together with MedCity and its industrial partners to strengthen interactions between local and overseas healthcare innovation ecosystems.

They aim to deepen cooperation on aspects including technology sourcing and transfer, capital financing and investment, and partnership network expansion.

AstraZeneca also entered a partnership with Israeli innovation incubator Trendlines at the forum. It will partner with Trendlines to promote the incubation of tech innovation firms and the commercialization of new technologies and therefore to fulfill the huge demand in the Chinese and global healthcare markets, leveraging on Trendlines' innovation strengths, research and development experience in the medical device industry and Israel's unique industrial incubation model and innovation capabilities, the company said.

In 2021, AstraZeneca's regional headquarters in northern China were officially inaugurated in Beijing, and the Beijing International Life Science Innovation Campus (Beijing iCampus) and the Community Intelligence Healthcare Innovation Center were also established in the city.

At the Forum, Beijing iCampus also welcomed a new round of five high-tech startups to its facilities. They will work together to integrate regional innovation ecosystem resources and empower the local smart healthcare industry.

Leon Wang, executive vice-president of AstraZeneca, and president of AstraZeneca China, said the company will leverage Beijing city's international industrial advantages to continue to expand its innovation ecosystem, enable the implementation of more innovative projects in the Chinese capital, and add momentum to the city's smart healthcare ecosystem. 

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
古交市| 株洲县| 那坡县| 冕宁县| 丰顺县| 阳山县| 亳州市| 馆陶县| 丘北县| 西华县| 柳林县| 雅安市| 无锡市| 黄陵县| 进贤县| 任丘市| 田东县| 东山县| 涞水县| 垫江县| 江阴市| 宁南县| 萝北县| 中江县| 高碑店市| 天祝| 定安县| 娱乐| 荔浦县| 曲沃县| 罗定市| 井陉县| 东明县| 定结县| 安平县| 登封市| 元阳县| 汾阳市| 周宁县| 江油市| 墨竹工卡县|